(Q46147193)

English

Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.

scientific article published on 23 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maria M Santoro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Carlo Federico Perno

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

CARe Study Group

18

object named as

CARe Study Group

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

P Lorenzini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

F Ceccherini-Silberstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

N Gianotti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C Mussini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C Torti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G Di Perri

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G Barbarini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

T Bini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S Melzi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

P Caramello

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Maserati

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

P Narciso

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

V Micheli

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A Antinori

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

23 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

233-243

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1007/s15010-008-8065-4

0 references

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance

1 reference

https://api.crossref.org/works/10.1007%2FS15010-008-8065-4

21 January 2018

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

1 reference

https://api.crossref.org/works/10.1007%2FS15010-008-8065-4

21 January 2018

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

1 reference

https://api.crossref.org/works/10.1007%2FS15010-008-8065-4

21 January 2018

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

1 reference

https://api.crossref.org/works/10.1007%2FS15010-008-8065-4

21 January 2018

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

1 reference

https://api.crossref.org/works/10.1007%2FS15010-008-8065-4

21 January 2018

Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of atazanavir (BMS-232632) against a large panel of human immunodeficiency virus type 1 clinical isolates resistant to one or more approved protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically validated genotype analysis: guiding principles and statistical concerns.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atazanavir: new option for treatment of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically relevant genotype interpretation of resistance to didanosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update of the drug resistance mutations in HIV-1: Fall 2005.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically relevant interpretation of genotype for resistance to abacavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S15010-008-8065-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169632%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46147193&oldid=1743156706"